Analytical Data
-
Gene name
ACYP1
- Application
-
Alternative Names
ACYPE; Acylphosphatase, erythrocyte isozyme; Acylphosphatase, organ-common type isozyme; Acylphosphate phosphohydrolase 1
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 95% as determined by SDS-PAGE.
-
Uniprot
P07311
-
Expression Region
Met1~Lys99
-
Molecular Weight
15.0kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ACYP1, or Acylphosphatase 1, is an enzyme that plays a crucial role in various metabolic processes, especially in muscle tissues. It functions by catalyzing the hydrolysis of acyl phosphate compounds, thereby facilitating cellular energy metabolism and regulating signaling pathways. Research on ACYP1 has gained significant attention due to its potential implications in muscle physiology and pathophysiology, including its involvement in muscle aging, atrophy, and various muscular diseases. Recombinant protein technology has emerged as a powerful tool for studying ACYP1, enabling researchers to produce large quantities of the enzyme in a controlled environment. This approach allows for detailed examination of its structural and functional properties, elucidating mechanisms of action and interactions with other cellular components. Moreover, understanding the role of ACYP1 in muscle metabolism may pave the way for novel therapeutic strategies aimed at combating muscle-related disorders. Consequently, the study of recombinant ACYP1 not only enhances our fundamental knowledge of muscle biology but also opens avenues for innovative treatments and interventions in conditions characterized by muscle dysfunction.
